Alison Turner

Title: Alison Turner: Innovator in Antibody Therapeutics

Introduction

Alison Turner is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents to her name, her work focuses on innovative solutions for treating various diseases.

Latest Patents

Alison Turner's latest patents include the development of antagonist antibodies that bind to human TGFB1, TGFB2, and TGFB3. These antibodies are designed for the treatment of lung fibrosis. The present disclosure relates to TGF-beta antibodies and binding fragments thereof, DNA encoding the same, host cells comprising said DNA, and methods of expressing the antibody or binding fragment in a host cell. The disclosure also extends to pharmaceutical compositions comprising the antibody or a binding fragment thereof, and the use of the antibody, binding fragment, and compositions in the treatment of various diseases, including fibrosis.

Career Highlights

Throughout her career, Alison has worked with notable companies such as UCB Biopharma and Celltech R&D Limited. Her experience in these organizations has allowed her to refine her expertise in antibody development and therapeutic applications.

Collaborations

Alison has collaborated with esteemed colleagues, including Helene Bon and Joanne Elizabeth Compson. These partnerships have contributed to her innovative research and advancements in the field.

Conclusion

Alison Turner is a trailblazer in the development of therapeutic antibodies, with a focus on addressing lung fibrosis. Her contributions to biotechnology continue to pave the way for new treatment options.